NEXGEN ENERGY LTD (NXE) Fundamental Analysis & Valuation

NYSE:NXE • CA65340P1062

Current stock price

12.71 USD
-0.39 (-2.98%)
At close:
12.73 USD
+0.02 (+0.16%)
After Hours:

This NXE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NXE Profitability Analysis

1.1 Basic Checks

  • NXE had negative earnings in the past year.
  • In the past year NXE has reported a negative cash flow from operations.
  • NXE had negative earnings in 4 of the past 5 years.
  • In the past 5 years NXE always reported negative operating cash flow.
NXE Yearly Net Income VS EBIT VS OCF VS FCFNXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • NXE has a worse Return On Assets (-12.52%) than 83.73% of its industry peers.
  • The Return On Equity of NXE (-16.90%) is worse than 76.56% of its industry peers.
Industry RankSector Rank
ROA -12.52%
ROE -16.9%
ROIC N/A
ROA(3y)-3.06%
ROA(5y)-8.23%
ROE(3y)-4.54%
ROE(5y)-10.93%
ROIC(3y)N/A
ROIC(5y)N/A
NXE Yearly ROA, ROE, ROICNXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NXE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXE Yearly Profit, Operating, Gross MarginsNXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

7

2. NXE Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for NXE has been increased compared to 1 year ago.
  • Compared to 5 years ago, NXE has more shares outstanding
  • The debt/assets ratio for NXE has been reduced compared to a year ago.
NXE Yearly Shares OutstandingNXE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
NXE Yearly Total Debt VS Total AssetsNXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 10.03 indicates that NXE is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 10.03, NXE belongs to the best of the industry, outperforming 93.30% of the companies in the same industry.
  • There is no outstanding debt for NXE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.03
ROIC/WACCN/A
WACCN/A
NXE Yearly LT Debt VS Equity VS FCFNXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • NXE has a Current Ratio of 1.82. This is a normal value and indicates that NXE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of NXE (1.82) is better than 71.77% of its industry peers.
  • A Quick Ratio of 1.82 indicates that NXE should not have too much problems paying its short term obligations.
  • NXE's Quick ratio of 1.82 is fine compared to the rest of the industry. NXE outperforms 74.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.82
NXE Yearly Current Assets VS Current LiabilitesNXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1

3. NXE Growth Analysis

3.1 Past

  • NXE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -80.48%.
EPS 1Y (TTM)-80.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • NXE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.78% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y70.98%
EPS Next 2Y-42.87%
EPS Next 3Y5.55%
EPS Next 5Y26.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NXE Yearly Revenue VS EstimatesNXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2024 2026 2027 2029 2030 2031 2032 2033 1B 2B 3B
NXE Yearly EPS VS EstimatesNXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4 -0.6

0

4. NXE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NXE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXE Price Earnings VS Forward Price EarningsNXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXE Per share dataNXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.87%
EPS Next 3Y5.55%

0

5. NXE Dividend Analysis

5.1 Amount

  • NXE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NXE Fundamentals: All Metrics, Ratios and Statistics

NEXGEN ENERGY LTD

NYSE:NXE (4/23/2026, 8:04:00 PM)

After market: 12.73 +0.02 (+0.16%)

12.71

-0.39 (-2.98%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-03
Earnings (Next)04-30
Inst Owners58.88%
Inst Owner Change-0.07%
Ins Owners2.09%
Ins Owner ChangeN/A
Market Cap7.73B
Revenue(TTM)N/A
Net Income(TTM)-309.68M
Analysts81
Price Target15.42 (21.32%)
Short Float %7.8%
Short Ratio5.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-328.26%
Min EPS beat(2)-570.22%
Max EPS beat(2)-86.3%
EPS beat(4)1
Avg EPS beat(4)-177.78%
Min EPS beat(4)-570.22%
Max EPS beat(4)241.44%
EPS beat(8)3
Avg EPS beat(8)-102.98%
EPS beat(12)4
Avg EPS beat(12)-109.7%
EPS beat(16)4
Avg EPS beat(16)-174.87%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)16.48%
PT rev (3m)31.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)31.51%
EPS NY rev (3m)33.19%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.76
P/tB 5.76
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS2.21
TBVpS2.21
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -12.52%
ROE -16.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.06%
ROA(5y)-8.23%
ROE(3y)-4.54%
ROE(5y)-10.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8436.32%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.82
Altman-Z 10.03
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)6886.25%
Cap/Depr(5y)5323.39%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-80.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.27%
EPS Next Y70.98%
EPS Next 2Y-42.87%
EPS Next 3Y5.55%
EPS Next 5Y26.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.63%
EBIT Next 3Y9.64%
EBIT Next 5Y46.64%
FCF growth 1Y-50.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.25%
OCF growth 3YN/A
OCF growth 5YN/A

NEXGEN ENERGY LTD / NXE Fundamental Analysis FAQ

What is the fundamental rating for NXE stock?

ChartMill assigns a fundamental rating of 2 / 10 to NXE.


Can you provide the valuation status for NEXGEN ENERGY LTD?

ChartMill assigns a valuation rating of 0 / 10 to NEXGEN ENERGY LTD (NXE). This can be considered as Overvalued.


What is the profitability of NXE stock?

NEXGEN ENERGY LTD (NXE) has a profitability rating of 0 / 10.


How financially healthy is NEXGEN ENERGY LTD?

The financial health rating of NEXGEN ENERGY LTD (NXE) is 7 / 10.